CLINICAL_TRIALS
research
· 2025-06-17
Clinical Trial Update: A Phase 1 Study of CD22-CAR TCell Immunotherapy for CD22+ Leukemia and Lymphoma [Phase 1]
Summary
Phase 1 clinical trial of CD22-CAR T cell immunotherapy for CD22-positive leukemia and lymphoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Seattle Children's Hospital | Conditions: Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING